Fingerprint
Dive into the research topics of 'Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: A children's oncology group phase I consortium study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically